We are live on ! Find out more
IART icon

Integra LifeSciences
IART

279 hedge funds and large institutions have $4.12B invested in Integra LifeSciences in 2019 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 104 increasing their positions, 82 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

28,659% more call options, than puts

Call options by funds: $4.89M | Put options by funds: $17K

27% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 82

16% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 38

1.37% more ownership

Funds ownership: 80.93% → 82.3% (+1.4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% less funds holding

Funds holding: 280 → 279 (-1)

1% less capital invested

Capital invested by funds: $4.16B → $4.12B (-$40M)

Holders
279
Holders Change
-1
Holders Change %
-0.36%
% of All Funds
5.5%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
44
Increased
104
Reduced
82
Closed
38
Calls
$4.89M
Puts
$17K
Net Calls
+$4.87M
Net Calls Change
+$3.54M

Top Buyers

Rank Fund Capital Flow
1
CB
Cooke & Bieler
Pennsylvania
+$105M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$64.7M
3
Goldman Sachs
Goldman Sachs
New York
+$23.4M
4
CIP
Champlain Investment Partners
Vermont
+$23.1M
5
EVM
Eaton Vance Management
Massachusetts
+$15.1M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$64.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$33.1M
3
Marshall Wace
Marshall Wace
United Kingdom
-$23.6M
4
CBT
Capital Bank & Trust
California
-$12.9M
5
Millennium Management
Millennium Management
New York
-$12M
Name Holding Trade Value Shares
Change 		Change in
Stake
VCM
276
Versant Capital Management
Arizona
$1K – – –
OPS
277
Orion Portfolio Solutions
Nebraska
$1K +$1.01K +17 New
Marshall Wace
278
Marshall Wace
United Kingdom
– -$23.6M -392,910 Closed
MWNA
279
Marshall Wace North America
New York
– -$10.3M -171,645 Closed
Adage Capital Partners
280
Adage Capital Partners
Massachusetts
– -$9.01M -150,000 Closed
ECM
281
Endurant Capital Management
California
– -$5.06M -84,225 Closed
N
282
Natixis
France
– -$3.54M -58,940 Closed
MPM
283
Meritage Portfolio Management
Kansas
– -$3M -49,913 Closed
AAMU
284
Amundi Asset Management US
Massachusetts
– -$2.81M -46,800 Closed
MSL
285
Mackay Shields LLC
New York
– -$1.74M -28,961 Closed
CC
286
Cipher Capital
New York
– -$1.32M -22,019 Closed
FI
287
Fosun International
China
– -$914K -15,400 Closed
ACM
288
AlphaCrest Capital Management
New York
– -$828K -13,777 Closed
TI
289
Trexquant Investment
Connecticut
– -$637K -10,602 Closed
PI
290
PEAK6 Investments
Illinois
– -$612K -10,186 Closed
Los Angeles Capital Management
291
Los Angeles Capital Management
California
– -$531K -8,848 Closed
AIL
292
AGF Investments LLC
Ontario, Canada
– -$464K -7,717 Closed
IAM
293
Integre Asset Management
New York
– -$431K -7,180 Closed
HF
294
HRT Financial
New York
– -$347K -5,789 Closed
QCM
295
Quantinno Capital Management
New York
– -$331K -5,513 Closed
SCM
296
Stevens Capital Management
Pennsylvania
– -$325K -5,412 Closed
LCM
297
Laurion Capital Management
New York
– -$319K -5,313 Closed
C
298
Cerebellum
California
– -$297K -4,946 Closed
PTC
299
Petrus Trust Company
Texas
– -$296K -4,934 Closed
FIM
300
Freedom Investment Management
Connecticut
– -$276K -4,587 Closed
9 10 11
12
13

IART Hedge Fund Activity: Q4 2019 in Review

279 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2019, worth a combined $4.12B — down 0.96% from $4.16B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new IART positions and 38 closed out — a net gain of 6 holders — while 104 added to existing stakes and 82 trimmed.

The largest buyer was Cooke & Bieler, opening a new position worth an estimated $105M. The largest seller was Invesco, cutting an estimated $64.9M.

  • 279 institutional investors held Integra LifeSciences (IART) as of Q4 2019, down from 280 in Q3 2019.
  • Funds reported $4.12B of Integra LifeSciences stock for Q4 2019, down 0.96% quarter-over-quarter.
  • 44 funds opened new Integra LifeSciences positions in Q4 2019 and 38 closed out, a net change of +6 holders.
  • The largest Integra LifeSciences buyer in Q4 2019 was Cooke & Bieler, an estimated $105M added.
  • The largest Integra LifeSciences seller in Q4 2019 was Invesco, an estimated $64.9M sold.

Based on aggregated 13F filings for Q4 2019.